Earnings History Data for Cara Therapeutics (CARA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.

Cara Therapeutics

Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
14-11-2024 AH CARA Cara Therapeutics 19.00 -0.15 -0.25 0.00 0.3075 -0.02 
(-6.14%)		 0.32 -0.01 
(-3.69%)		 0.24 - 1.31 519,073 960,000 5,431
13-05-2024 AH CARA Cara Therapeutics, Inc. 41.54 -0.56 -0.38 -0.49 Cara Therapeutics GAAP EPS of -$0.56 misses by $0.17, revenue of $2.14M beats by $0.45M
[5/13/2024 4:05 PM]		 0.7165 -0.03 
(-4.50%)		 0.74 -0.01 
(-1.37%)		 0.50 - 4.67 283,003 220,000 2,172
04-03-2024 AH CARA Cara Therapeutics 46.00 -0.59 -0.57 0.00 Cara Therapeutics GAAP EPS of -$0.59 misses by $0.23, revenue of $3M misses by $6.13M
[3/4/2024 4:02 PM]		 0.91 -0.09 
(-8.98%)		 0.88 -0.12 
(-12.02%)		 0.50 - 10.28 1,129,572 1,410,000 19,678
13-11-2023 AH CARA Cara Therapeutics, Inc. 60.03 -0.52 -0.53 -0.43 Cara Therapeutics GAAP EPS of -$0.52 beats by $0.01, revenue of $4.87M misses by $5.08M
[11/13/2023 4:02 PM]		 1.08 -0.09 
(-8.05%)		 1.17 -0.01 
(-0.85%)		 1.02 - 12.81 865,813 430,000 29,698
07-08-2023 AH CARA Cara Therapeutics, Inc. 172.21 -0.58 -0.56 -0.08 Cara Therapeutics GAAP EPS of -$0.58 misses by $0.04, revenue of $6.93M beats by $0.23M
[8/7/2023 4:13 PM]		 2.92 -0.03 
(-0.85%)		 2.85 -0.10 
(-3.39%)		 2.57 - 12.98 1,370,308 710,000 652
15-05-2023 AH 4:00 PM ET
(May 15)		 CARA Cara Therapeutics, Inc. 217.52 -0.49 -0.53 -0.52 Cara Therapeutics GAAP EPS of -$0.49 beats by $0.03, revenue of $6.17M beats by $1.19M
[5/15/2023 4:02 PM]		 4.45 0.29 
(7.11%)		 4.25 0.10 
(2.41%)		 3.89 - 12.98 2,539,675 460,000 9,310
06-03-2023 AH 4:00 PM ET
(Mar 6)		 CARA Cara Therapeutics, Inc. 557.22 -0.56 -0.33 -0.63 Cara Therapeutics GAAP EPS of -$0.56 misses by $0.20, revenue of $3.26M misses by $11.24M
[3/6/2023 4:02 PM]		 6.59 -3.43 
(-34.23%)		 7.28 -2.74 
(-27.35%)		 6.58 - 13.97 5,082,484 400,000 260,121
07-11-2022 AH 4:00 PM ET
(Nov 7)		 CARA Cara Therapeutics, Inc. 493.74 -0.43 -0.42 -0.02 Cara Therapeutics GAAP EPS of -$0.43 beats by $0.01, revenue of $10.81M beats by $1.95M
[11/7/2022 4:04 PM]		 9.55 0.21 
(2.25%)		 9.35 0.01 
(0.11%)		 7.40 - 18.93 564,191 380,000 690
08-08-2022 AH 4:00 PM ET
(Aug 8)		 CARA Cara Therapeutics, Inc. 520.37 -0.08 -0.28 -0.61 Cara Therapeutics GAAP EPS of -$0.08 beats by $0.18, revenue of $23M beats by $1.97M
[8/8/2022 4:26 PM]		 11.82 0.32 
(2.78%)		 10.95 -0.55 
(-4.78%)		 7.40 - 18.93 827,138 560,000 2,019
09-05-2022 AH 4:00 PM ET
(May 9)		 CARA Cara Therapeutics, Inc. 452.85 -0.52 -0.56 -0.47 Cara Therapeutics GAAP EPS of -$0.52 beats by $0.10, revenue of $4.79M beats by $2.53M
[5/9/2022 4:03 PM]		 9.21 1.76 
(23.62%)		 7.20 -0.25 
(-3.36%)		 7.40 - 18.93 2,184,604 750,000 6,923
01-03-2022 AH 4:00 PM ET
(Mar 1)		 CARA Cara Therapeutics, Inc. 559.18 -0.63 -0.50 1.59 Cara Therapeutics GAAP EPS of -$0.63 misses by $0.11, revenue of $0.82M misses by $0.43M
[3/1/2022 4:08 PM]		 11.53 1.47 
(14.61%)		 9.78 -0.28 
(-2.78%)		 9.63 - 29.65 1,076,198 540,000 1,583
08-11-2021 AH 4:00 PM ET
(Nov 8)		 CARA Cara Therapeutics, Inc. 884.09 -0.02 -0.36 -0.35 Cara Therapeutics EPS beats by $0.40, beats on revenue
[11/8/2021 4:03 PM]		 18.17 0.94 
(5.46%)		 17.36 0.13 
(0.75%)		 11.22 - 29.65 1,185,033 1,410,000 3,752
09-08-2021 AH 4:00 PM ET
(Aug 9)		 CARA Cara Therapeutics, Inc. 599.12 -0.61 -0.55 -0.54 Cara Therapeutics EPS misses by $0.04
[8/9/2021 4:02 PM]		 13.00 0.49 
(3.92%)		 12.45 -0.06 
(-0.48%)		 11.22 - 29.65 976,450 600,000 11,916
10-05-2021 AH 4:00 PM ET
(May 10)		 CARA Cara Therapeutics, Inc. 654.04 -0.47 -0.62 -0.62 Cara Therapeutics EPS beats by $0.12, misses on revenue
[5/10/2021 4:05 PM]		 13.01 0.63 
(5.09%)		 12.00 -0.38 
(-3.07%)		 11.80 - 29.65 980,419 2,570,000 9,935
25-02-2021 AH 4:00 PM ET
(Feb 25)		 CARA Cara Therapeutics, Inc. 998.14 1.59 -0.53 -0.61 Cara Therapeutics EPS beats by $1.11, beats on revenue
[2/25/2021 4:04 PM]		 18.41 -0.85 
(-4.41%)		 19.40 0.14 
(0.73%)		 8.88 - 22.60 497,483 577,760 3,066
09-11-2020 AH 4:00 PM ET
(Nov 9)		 CARA Cara Therapeutics, Inc. 651.26 -0.35 -0.68 -0.74 Cara Therapeutics EPS beats by $0.24, beats on revenue
[11/9/2020 4:04 PM]		 15.03 0.52 
(3.58%)		 15.00 0.49 
(3.38%)		 8.88 - 26.67 631,229 350,467 2,146
10-08-2020 AH 4:00 PM ET
(Aug 10)		 CARA Cara Therapeutics, Inc. 794.60 -0.54 -0.68 -0.58 Cara Therapeutics EPS beats by $0.12, beats on revenue
[8/10/2020 4:06 PM]		 18.35 1.13 
(6.56%)		 17.39 0.17 
(0.99%)		 8.88 - 26.67 583,156 293,027 354